Revised: 11 July 2018

Policy Statements

Date Policy
11 June 2018 What to do in the case of a potential out of stock
21 June 2017 Change to Label Statement Database for OTC loratadine and desloratadine medicines
18 April 2017 Tips for changing to the new data sheet format
19 October 2016 Reminder to sponsors: Timeframes for provisional consent
20 July 2015 Changes to Priority Assessment Process
28 May 2014 Changes to the Definition of Medicines and Medical Devices Effective 1 July 2014
2 May 2014 Biosimilars
1 February 2013 Update to Therapeutic Product Database Reports
January 2012 Acceptability of Claims for Pain Relief

Previous policy statements have been incorporated into the Guidelines.